文献速递瓣膜病与结构性心脏病

经导管二尖瓣置换术的现状与未来展望:JACC最新综述

Current Status and Future Prospects of Transcatheter Mitral Valve Replacement: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2021-01-01

二尖瓣反流是最常见的瓣膜性心脏病,未治疗则预后较差。经导管二尖瓣修复存在解剖适用性限制和远期复发问题,经导管二尖瓣置换术(TMVR)作为微创替代方案正在临床研究中。该综述梳理了TMVR领域的主要挑战、术前规划要点及在研系统的临床结果,并展望未来方向。

要点

  • TMVR为不适合修复或修复后复发的二尖瓣反流患者提供微创选择
  • 多种TMVR装置在研,经股静脉全 percutaneous 入路系统增多
  • 术前规划需综合评估解剖、入路及器械适配性以降低并发症

核心结论

  • TMVR作为微创方法有望克服经导管二尖瓣修复的部分局限,但仍在临床研究阶段。

研究设计与样本

  • 本文为JACC最新综述,旨在阐述TMVR领域的主要挑战、术前规划关键要点及在研系统的临床结果。

主要发现

  • 多种TMVR装置正在进行临床研究,越来越多的系统支持经股静脉全 percutaneous 入路。
  • 经导管二尖瓣修复存在挑战性解剖适用性有限及显著二尖瓣反流可能随时间复发等局限。

临床怎么用

  • 对二尖瓣反流患者评估时,需考虑TMVR作为修复治疗替代方案的潜力,但应限于临床研究框架内。
  • TMVR术前规划需重点关注解剖适用性、入路方式和器械选择。

局限性

  • 本文为综述,未报告原始研究数据或定量合并结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mitral regurgitation (MR) is the most prevalent valvular heart disease and, when left untreated, it confers a poorer prognosis. Catheter-based repair therapies face some limitations like their applicability on challenging anatomies and the potential recurrence of significant MR over time. Transcatheter mitral valve replacement (TMVR) has emerged as a less invasive approach potentially overcoming some of the current limitations associated with transcatheter mitral valve repair. Several devices are under clinical investigation, and a growing number of systems allow for a fully percutaneous transfemoral approach. In this review, the authors aimed to delineate the main challenges faced by the TMVR field, to highlight the key aspects for procedural planning, and to describe the clinical results of the TMVR systems under clinical investigation. Finally, they also discuss what the future perspectives are for this emerging field.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Alperi A, Granada JF, Bernier M, et al. Current Status and Future Prospects of Transcatheter Mitral Valve Replacement: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021. PMID: 34140110. doi:10.1016/j.jacc.2021.04.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。